http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6482987-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5794c26283c1d2f21e58960b8175566
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2001-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca1052f5d57ed5f35560887202dd6d11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4665b138b75c06cb9604a31a348213b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc7980b9ac96ef8ad26f53cbc6b3a4cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1558e086d13d41ca06b32c36e5769c38
publicationDate 2002-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6482987-B2
titleOfInvention Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
abstract Novel, stable formulations of bupropion hydrochloride are provided which will maintain at least 80% of initial bupropion hydrochloride potency after one year. Methods of inhibiting degradation of bupropion hydrochloride and methods of preparing stable formulations of bupropion hydrochloride are also provided.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7537784-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10610528-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703191-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006204571-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7674479-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008026060-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9717682-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008031948-A1
priorityDate 1997-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE33994-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5731000-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5358970-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5427798-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3819706-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226607155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226607156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415887923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID228879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3036261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128479188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14055602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62884
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129262404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21121987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449812109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449630271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449349091

Total number of triples: 54.